Riyadh
Saudi Arabia · 12 retained evidence mentions
Source-grounded findings
Supporting evidence
| Type | Entity | Source evidence | Confidence | Extractor |
|---|---|---|---|---|
| population | Saudi Arabia, Riyadh | “Detection of SARS-CoV-2 in nasopharyngeal swab samples from COVID-19 patients in Riyadh, Saudi Arabia: a PCR-based study. This study involved laboratory experiments using conventional PCR to detect the RNA-dependent RNA polymerase protein (RdRp) and Envelope (E) genes in Forty-Seven nasopharyngeal swab samples from COVID-19 patients in Riyadh, Saudi Arabia. A significant portion (60.56%) had not contacted positive cases or traveled outside Saudi Arabia (P ≤ 0.05). The Saudi to non-Saudi ratio among patients was 24.65-75.35% (P ≤ 0.05).” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters. METHODS: This retrospective investigation uses repeated measures to examine changes in hematological and biochemical parameters among patients with acute leukemia before and after COVID-19 infection at a major Saudi tertiary center. The investigation was conducted at the Ministry of National Guard-Health Affairs in Riyadh, Saudi Arabia, on 24 acute leukemia patients with COVID-19 between April 2020 and July 2023.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “This study was performed at the Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia. CONCLUSION: The need for comprehensive research is urgent, as it will facilitate a better understanding of the physiological aspects of COVID-19 for patients with diabetes.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “Epidemiological characteristics, clinical course, and laboratory investigation of pediatric COVID-19 patients in a tertiary care center in Saudi Arabia. METHODS: A retrospective review of findings associated with 143 pediatric patients (age <14 years) with a confirmed COVID-19 diagnosis who had undergone inpatient or outpatient treatment at King Faisal Specialist Hospital and Research Center in Riyadh, Saudi Arabia, between March 2020 and October 2020, was conducted.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “External Validation of 4C ISARIC Mortality Score in Critically ill COVID-19 Patients from Saudi Arabia. OBJECTIVES: External validation of the ISARIC mortality score in COVID-19 patients from a large Saudi Arabian intensive care unit (ICU). METHODS: This is a retrospective study that included all adult patients with COVID-19 admitted to the ICU of King Saud Medical City, Riyadh, Saudi Arabia, from March 2020 to June 2021. CONCLUSION: The ISARIC score was found to have excellent predictive ability for mortality in critically ill COVID-19 patients in our Saudi Arabian cohort.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “Outcome of COVID19 in Patients With Osteogenesis Imperfecta: A Retrospective Multicenter Study in Saudi Arabia. There is no literature describing the impact of COVID-19 in patients with OI. METHODOLOGY: A retrospective multi-center study was performed in three hospitals in Jeddah and Riyadh, Saudi Arabia, from March 1st, 2020, until August 31st, 2021, aiming to evaluate the outcome of COVID-19 in patients with OI.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “In the wake of the COVID-19 pandemic, research indicates that the COVID-19 disease susceptibility varies among individuals depending on their ABO blood groups. The current study investigates whether clinical manifestation, laboratory, and imaging findings vary among ABO blood groups of hospitalized confirmed COVID-19 patients.This retrospective cohort study was conducted between March 1, 2020 and March 31, 2021 in King Faisal Specialist Hospital and Research Centre Riyadh and Jeddah, Saudi Arabia. This was almost consistent with the distribution of blood groups among the Saudi Arabia community.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “Clinical Presentation and Successful Management of an Infant With Down Syndrome and COVID-19 in Riyadh, Saudi Arabia. Here, we report the first case of COVID-19 in a four-month-old infant girl with DS and congenital heart disease (CHD) who was treated in Al-Imam Abdulrahman Al Faisal Hospital in the first health cluster in Riyadh, Saudi Arabia.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “Hypokalemia, which is a life-threatening condition that may lead to arrhythmia and possibly death, has been noticed in more than half of the COVID-19 patients. CASE PRESENTATION: A 34-year old male from Philippines who lives in Saudi Arabia - Riyadh and works as health care provider with no previous history of any medical illness.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “COVID-19 in children ranging from asymptomatic to a multi-system inflammatory disease: A single-center study. OBJECTIVES: To identify clinical and laboratory characteristics of the Saudi children with confirmed COVID-19. METHODS: Eighty-eight children (0-14 years) with COVID-19 who were admitted to Prince Sultan Military Medical City (PSMMC), Riyadh, Saudi Arabia from April to June 2020 were recruited. CONCLUSIONS: Identifying the clinical and laboratory characteristics of the Saudi children with confirmed COVID-19 will improve understanding of this disease's presentation and will help put rapid and proper management strategies into place to face this pandemic.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “Role of pharmacist during COVID-19 pandemic: A retrospective study focused on critically ill COVID-19 patients. METHODS: A retrospective study, was conducted in Diriyah hospital in Riyadh, Saudi Arabia on all COVID-19 patients admitted to the ICU between June 27th and August 15th, 2020 until patients were transferred to the medical ward, discharged, or deceased.” | 0.95 | saudi_context_rules_v1 |
| population | Saudi Arabia, Riyadh | “This study was conducted on 26 sickle cell disease (SCD) patients from Yemen and 19 normal children (Hb AA) living in Riyadh, Saudi Arabia.” | 0.95 | saudi_context_rules_v1 |